Squarepoint’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-105,156
| Closed | -$454K | – | 3104 |
|
2024
Q1 | $454K | Buy |
105,156
+88,938
| +548% | +$384K | ﹤0.01% | 1720 |
|
2023
Q4 | $49.5K | Buy |
16,218
+3,403
| +27% | +$10.4K | ﹤0.01% | 2367 |
|
2023
Q3 | $18.5K | Buy |
+12,815
| New | +$18.5K | ﹤0.01% | 2391 |
|
2023
Q2 | – | Sell |
-27,455
| Closed | -$73.6K | – | 2943 |
|
2023
Q1 | $73.6K | Sell |
27,455
-21,859
| -44% | -$58.6K | ﹤0.01% | 2073 |
|
2022
Q4 | $268K | Buy |
49,314
+1,133
| +2% | +$6.15K | ﹤0.01% | 1748 |
|
2022
Q3 | $602K | Buy |
48,181
+27,255
| +130% | +$341K | ﹤0.01% | 1330 |
|
2022
Q2 | $103K | Buy |
20,926
+8,607
| +70% | +$42.4K | ﹤0.01% | 1867 |
|
2022
Q1 | $94K | Sell |
12,319
-2,520
| -17% | -$19.2K | ﹤0.01% | 2034 |
|
2021
Q4 | $152K | Buy |
+14,839
| New | +$152K | ﹤0.01% | 2201 |
|
2021
Q3 | – | Sell |
-9,332
| Closed | -$205K | – | 2864 |
|
2021
Q2 | $205K | Buy |
+9,332
| New | +$205K | ﹤0.01% | 2215 |
|
2021
Q1 | – | Sell |
-11,919
| Closed | -$214K | – | 3149 |
|
2020
Q4 | $214K | Sell |
11,919
-92,549
| -89% | -$1.66M | ﹤0.01% | 2093 |
|
2020
Q3 | $1.21M | Buy |
104,468
+83,308
| +394% | +$963K | 0.02% | 855 |
|
2020
Q2 | $513K | Sell |
21,160
-33,924
| -62% | -$822K | 0.01% | 1291 |
|
2020
Q1 | $607K | Buy |
55,084
+35,466
| +181% | +$391K | 0.02% | 931 |
|
2019
Q4 | $519K | Sell |
19,618
-13,253
| -40% | -$351K | ﹤0.01% | 1713 |
|
2019
Q3 | $749K | Buy |
32,871
+26,067
| +383% | +$594K | 0.01% | 1372 |
|
2019
Q2 | $209K | Buy |
+6,804
| New | +$209K | ﹤0.01% | 2022 |
|
2019
Q1 | – | Sell |
-62,233
| Closed | -$1.19M | – | 2439 |
|
2018
Q4 | $1.19M | Buy |
62,233
+31,498
| +102% | +$603K | 0.01% | 840 |
|
2018
Q3 | $1.61M | Buy |
30,735
+12,435
| +68% | +$650K | 0.02% | 798 |
|
2018
Q2 | $795K | Buy |
+18,300
| New | +$795K | 0.01% | 982 |
|